Before Buyers Push Back: How to Defend Your Valuation With More Credibility
Before Buyers Push Back: How to Defend Your Valuation With More Credibility Key Takeaways Why Buyers Push Back on Valuations In healthcare M&A, buyers frequently push back to mitigate perceived risk, scrutinizing revenue quality, EBITDA trends, and patient mix, often discounting inflated projections. By following strategies outlined in Process Without Pressure: How Agencies Keep Momentum […]
Read More
How to Know If Your Healthcare Company Has Reached Institutional Deal Level
How to Know If Your Healthcare Company Has Reached Institutional Deal Level Key Takeaways Recognizing Institutional Deal Readiness Institutional buyers evaluate businesses beyond revenue, focusing on scalability, consistency, and repeatable processes. Companies with organized operations, clear KPIs, and reliable reporting are more likely to attract serious investment. Partnering with a professional healthcare M&A firm […]
Read More
Exit Planning for Founders Who Want Optionality, Not Finality
Exit Planning for Founders Who Want Optionality, Not Finality Key Takeaways Understanding Exit Optionality vs. Finality When founders think about exiting their business, the instinct often leans toward “one-and-done.” Many assume that a final sale is the ultimate goal. While this might suit some entrepreneurs, it isn’t the ideal strategy for those who want strategic […]
Read More
The Critical Numbers That Make or Break Healthcare M&A Transactions
The Critical Numbers That Make or Break Healthcare M&A Transactions Key Takeaways Introduction Healthcare mergers and acquisitions (M&A) are complex transactions that demand meticulous financial, operational, and strategic analysis. Unlike other industries, healthcare deals involve unique considerations such as patient volume, payer mix, and regulatory compliance. Understanding which numbers matter most can mean the difference […]
Read More